557 hasil
Menampilkan 1–20 · 0,65 detik · RSS
Neurotherapeutics
Scopus
ISSN 1878-7479 · Elsevier · 557 artikel di indeks
-
Artikel Jurnal
Plasma levels of thrombin-cleaved osteopontin as a surrogate biomarker of subsequent chronic shunt-dependent hydrocephalus development following aneurysmal subarachnoid hemorrhage
Chronic shunt-dependent hydrocephalus (SDHC) is a major contributor to poor outcome after aneurysmal subarachnoid hemorrhage (aSAH), reportedly with arachnoid fibrosis implicated in its pathophysiology. In the pathogenesis of fibrosis, N-terminal half of osteopontin (OPN N-half), generated via…
-
Artikel Jurnal
Blood-brain barrier penetration determines link between beta blockers and reduced mortality in patients with sepsis-associated encephalopathy: A multicenter cohort study and an effect heterogeneity tool
Clinical evidence for beta (β) blockers in sepsis-associated encephalopathy (SAE) is limited, and the influence of blood-brain barrier penetration (BBBp) on their neuroprotective efficacy remains unclear. We analyzed 17,446 SAE patients from the Medical Information Mart in Intensive Care (MIMIC)-Ⅳ…
-
Artikel Jurnal
Intravenous miR-30c therapy confers dual neurovascular protection and improves long-term recovery after ischemic stroke
Ischemia–reperfusion (I/R) injury is a major barrier to effective reperfusion therapy in acute ischemic stroke. Secondary microvascular thrombosis and neuronal endoplasmic reticulum (ER) stress are major contributors to poor outcomes, yet therapeutic strategies that simultaneously target both…
-
Artikel Jurnal
Novel therapeutics in autism spectrum disorder
Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental condition with limited treatment options that address its full complexity. This review critically evaluates novel therapeutics across five key domains: behavioral and psychosocial interventions, psychopharmacology, digital and…
-
Artikel Jurnal
Silmitasertib, an FDA-designated orphan CK2 inhibitor, ameliorates neuropathology and motor dysfunction in a Huntington's disease mouse model
Huntington's disease (HD) is a devastating autosomal dominant neurodegenerative disease that manifests with progressive motor, cognitive, and psychological impairments. HD is caused by a CAG (glutamine) repeat expansion in the huntingtin (HTT) gene, leading to the misfolding and aggregation of…
-
Artikel Jurnal
Down-regulation of lipocalin-2 alleviates depressive-like behaviors in mice through modulation of microglial activation
Although the pathophysiological underpinnings of major depressive disorder (MDD) are increasingly recognized to involve microglia-mediated neuroinflammation, the underlying molecular processes are still not fully understood. To identify key molecular regulators associated with neuroinflammatory…
-
Artikel Jurnal
KITENIN-CCL20 axis is a potential therapeutic target for modulating immunosuppressive tumor microenvironment in glioblastoma
Glioblastoma (GBM) is characterized by an immunosuppressive tumor microenvironment (TME), limiting the effectiveness of existing treatments. We investigated the role of KAI1 COOH-terminal interacting tetraspanin (KITENIN), a metastasis-promoting protein, in mediating this immunosuppression…
-
Artikel Jurnal
Neuron-glioma synaptic transmission amplified by free 19S proteasome-mediated AMPAR deubiquitination promotes tumor progression
Glioma progression is closely linked to neuronal activity. Glutamatergic neurons form functional synapses with glioma cells (neuron-glioma synapses, NGS), directly promoting tumor growth via electrophysiological signaling. However, the key molecular regulators of NGS remain unclear. This study aims…
-
Artikel Jurnal
Heterogeneous Deep Gray Matter Iron Deposition Patterns across Multiple Sclerosis Subgroups Defined by the Clinico-Radiological Paradox
The clinico-radiological paradox in multiple sclerosis (MS) describes the disconnect between white matter lesion load and clinical disability. This study investigated the role of deep gray matter (DGM) iron deposition in this paradox, specifically regarding cognitive impairment. We classified 134…
-
Artikel Jurnal
Advances in Treatment of Psychiatric Disorders in Patients with HIV
Psychiatric disorders have been shown to be risk factors for infection with HIV but have also been shown to be consequences of HIV infection, as well as barriers to effective care. Psychiatric disorders are associated with poor treatment outcomes, increased morbidity and mortality. Integrated care…
-
Artikel Jurnal
Revisiting elevated HDL cholesterol, cerebral hemodynamic improvement in asymptomatic carotid artery disease: A longitudinal 15O-Gas PET study
Interventional trials with high-density lipoprotein cholesterol (HDL-C)-raising drugs have generally failed to demonstrate a beneficial effect on cardiovascular outcomes, although low HDL-C levels confer the risk of cerebrocardiovascular diseases. Previous experimental studies indicate that HDL-C…
-
Artikel Jurnal
Mapping the genetic landscape of suicide risk: Insights from genomic SEM
The genetic basis of traits associated with suicide risk remains poorly understood. We applied genomic structural equation modeling and integrated multiple post-genome-wide association study (GWAS) analysis strategies to identify potential causal single-nucleotide polymorphisms independent of known…
-
Artikel Jurnal
Microglial GM3 accumulation impairs Aβ phagocytic activity and promotes neuroinflammation in Alzheimer's disease
Growing evidence underscores the critical role of lipid metabolism in the pathogenesis of Alzheimer's disease (AD). We previously demonstrated that 5xFAD mice exhibit a marked accumulation of ganglioside GM3 in the cerebral cortex and hippocampus as the disease progresses, with this increase being…
-
Artikel Jurnal
Parkin protects against traumatic brain injury through regulating mitochondrial quality control
Traumatic brain injury (TBI) is a critical neurological condition, with neuronal damage being its fundamental pathological basis. However, molecular targets for the prevention and treatment of neuronal injury remain to be further explored. Parkin is an important molecule closely associated with…
-
Artikel Jurnal
Transcranial direct current stimulation is safe and feasible in hyperacute ischemic stroke (DICAST-SF trial)
Cathodal transcranial direct current stimulation (C-tDCS) is a potential neuroprotective method in the hyperacute phase of ischemic stroke. We aimed to assess safety, tolerability, feasibility, and potential efficacy of C-tDCS in stroke patients with salvageable penumbra. DICAST-SF was a…
-
Artikel Jurnal
Single-dose psilocybin promotes cell-type-specific changes of neurons in the orbitofrontal cortex
Recent clinical breakthroughs hold great promise for the application of psilocybin in the treatments of psychological disorders, such as depression, addiction, and obsessive-compulsive disorder. Psilocybin is a psychedelic whose metabolite, psilocin, is a 5-HT2A receptor agonist. Nevertheless, the…
-
Artikel Jurnal
Targeting dual specificity tyrosine-phosphorylation-regulated kinase 1A mitigates tauopathy and enhances recovery after repetitive head injury
Chronic neuroinflammation and accumulation of phosphorylated Tau (pTau) are hallmark features of several neurodegenerative diseases and are also observed in some individuals who have sustained traumatic brain injury (TBI). Notably, more than 70 % of patients presenting to emergency departments with…
-
Artikel Jurnal
Hypoactivity of the prelimbic cortex projecting to the lateral entorhinal cortex contributes to neuropathic pain-induced object recognition memory impairment in mice
Memory impairment is a common comorbidity of chronic pain that significantly compromises patients’ quality of life, yet the underlying neuronal circuit mechanisms remain poorly understood. Here, we employed a spared nerve injury (SNI) mouse model of chronic neuropathic pain and evaluated short-term…
-
Artikel Jurnal
Nabiximols improves sleep architecture in multiple sclerosis: A prospective polysomnographic study
We aim to evaluate sleep disruption in people with multiple sclerosis (MS) compared to an age- and gender-matched control cohort using patient-reported outcome measures and formal polysomnography (PSG) scoring, and testing the effect of Nabiximols on these measures in people with MS. We enrolled…